549 related articles for article (PubMed ID: 9372863)
1. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
2. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
Sur P; Nandi N; Ghosh P; Ghosh NC
Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
[TBL] [Abstract][Full Text] [Related]
3. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea derivatives: oxamyl hydroxamic acid.
Gale GR
Cancer Res; 1966 Nov; 26(11):2340-8. PubMed ID: 5334143
[No Abstract] [Full Text] [Related]
5. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
Gupta M; Mazumder UK; Kumar RS; Kumar TS
Acta Pharmacol Sin; 2004 Aug; 25(8):1070-6. PubMed ID: 15301742
[TBL] [Abstract][Full Text] [Related]
6. New potential cytotoxic and antitumor substances. II. Effect of hydroxyanthraquinones and their glucosides on Ehrlich ascites carcinoma cells in vitro.
Fuska J; Fusková A; Vanĕk Z
Neoplasma; 1976; 23(2):227-30. PubMed ID: 934391
[TBL] [Abstract][Full Text] [Related]
7. Biological time and the effects of hydroxyurea on DNA synthetic activity of bone marrow and tumor cells in mice bearing the Ehrlich ascites carcinoma.
Burns ER
Am J Anat; 1987 Jul; 179(3):308-13. PubMed ID: 3630958
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory action of retinoic acid and N-(4-carboxyphenyl)-retinamide on the biosynthesis of DNA, RNA and protein in Ehrlich ascites carcinoma].
Song ZP; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Dec; 6(6):418-20. PubMed ID: 6242543
[No Abstract] [Full Text] [Related]
10. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
[TBL] [Abstract][Full Text] [Related]
11. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
13. Enhanced inhibitory effects of hyperthermia combined with ascorbic acid on DNA synthesis in Ehrlich ascites tumor cells grown at a low cell density.
Kageyama K; Onoyama Y; Otani S; Matsui-Yuasa I; Nagao N; Miwa N
Cancer Biochem Biophys; 1995 Jan; 14(4):273-80. PubMed ID: 7767901
[TBL] [Abstract][Full Text] [Related]
14. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
15. [Cytotoxic and antitumor effect of antibiotic PSX-1 in vitro and in vivo].
Fuchs J
Antibiotiki; 1977 Apr; 22(4):361-5. PubMed ID: 883790
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
18. The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth.
Terlikowski S; Sulkowska M; Nowak HF
J Environ Pathol Toxicol Oncol; 2002; 21(1):87-92. PubMed ID: 11934018
[TBL] [Abstract][Full Text] [Related]
19. Isolation, purification and antitumor activity of lipopolysaccharide from cow placenta.
Li H; Lu X; Lu M; Liu H
Int J Biol Macromol; 2008 Oct; 43(3):232-7. PubMed ID: 18582932
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
